• 1. Nitrile hydration catalysed by palladium(II) complexes
  Natalia V. Kaminskaia,Nenad M. Kosti? J. Chem. Soc. Dalton Trans. 1996 3677
• 2. Interplay between the palladium(II) ion, unidentate ligands and hydroxyl groups from a bidentate ligand in a new complex that catalyses hydration and alcoholysis of nitrile and urea??
  Natalia V. Kaminskaia,Ilia A. Guzei,Nenad M. Kosti? J. Chem. Soc. Dalton Trans. 1998 3879
• 3. Cadmium(II), bismuth(III), lead(II) and thallium(I) crown thioether chemistry: synthesis and crystal structures of [(CdI2)2([24]aneS8)], [(BiCl3)2([24]aneS8)], [Pb2([28]aneS8)][ClO4]4 and [Tl([24]aneS8)]PF6 ([24]aneS8?=?1,4,7,10,13,16,19,22-octathiacyclotetracosane; [28]aneS8?=?1,4,8,11,15,18,22,25-octathiacyclooctacosane)
  Alexander J. Blake,Dieter Fenske,Wan-Sheung Li,Vito Lippolis,Martin Schr?der J. Chem. Soc. Dalton Trans. 1998 3961

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Secondary alcohols
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alcohols and polyols Secondary alcohols

1,5-DITHIACYCLOOCTAN-3-OL (CAS No. 86944-00-5): A Comprehensive Overview of Its Chemistry and Applications

The 1,5-dithiacyclooctan-3-ol, identified by the CAS No. 86944-00-5, is a cyclic organosulfur compound with a unique structural framework comprising an eight-membered ring fused with two sulfur atoms at positions 1 and 5. This molecule has garnered significant attention in recent years due to its versatile reactivity and potential applications in medicinal chemistry, materials science, and catalytic systems. Recent studies highlight its role as a promising scaffold for developing novel therapeutic agents targeting oxidative stress-related disorders.

Structurally, the 1,5-dithiacyclooctan-3-ol features a rigid bicyclic core stabilized by sulfur atoms, which confer enhanced thermal stability compared to analogous oxygen-containing rings. The presence of the hydroxyl group at position 3 introduces nucleophilic reactivity, enabling facile functionalization through etherification or esterification reactions. Spectroscopic analyses confirm its planar geometry with bond angles optimized for π-electron delocalization across the sulfur-containing ring system—a property that underpins its redox activity observed in electrochemical studies published in Journal of Organic Chemistry (2022).

Synthetic advancements have significantly expanded access to this compound. Traditional routes involving thionation of cyclooctanediols have been refined through microwave-assisted protocols reported in Green Chemistry, achieving >90% yields under solvent-free conditions. Recent innovations leverage organocatalytic strategies using proline derivatives to construct the sulfur ring via [2+2+2] cycloaddition pathways described in Nature Communications (2023). These methods reduce reaction times from days to hours while eliminating hazardous reagents like Lawesson's reagent.

In pharmacological studies, the 1,5-dithiacyclooctan-3-ol exhibits remarkable antioxidant capacity attributed to its ability to scavenge free radicals via sulfur-centered radical intermediates. Preclinical data from Bioorganic & Medicinal Chemistry Letters (2023) demonstrate its neuroprotective effects in Parkinson’s disease models by inhibiting α-synuclein aggregation—a mechanism linked to its amphiphilic nature where the hydrophobic ring interacts with protein aggregates while the hydroxyl group stabilizes metal ions.

Beyond medicinal applications, this compound serves as a high-performance ligand in transition metal catalysis. Its chelating properties enable efficient asymmetric hydrogenation catalysts for producing chiral pharmaceutical intermediates at industrial scales. A breakthrough study published in Angewandte Chemie International Edition (2024) showed palladium complexes derived from this scaffold achieved enantioselectivities exceeding 98% ee under mild conditions.

In material science contexts, self-assembled monolayers formed by alkyl derivatives of this compound exhibit exceptional corrosion resistance when applied to biomedical implants. Tribological tests published in Advanced Materials Interfaces revealed friction coefficients reduced by up to 67% compared to conventional coatings—a property arising from the sulfur-containing ring’s ability to form lubricious dithiocarbamate layers under physiological conditions.

The latest research directions focus on exploiting this compound’s photoresponsive properties discovered through UV-vis spectroscopy studies conducted at MIT’s Catalysis Center (preprint 2024). Upon light irradiation at ~365 nm wavelength, reversible structural isomerization occurs between chair and boat conformations—opening avenues for stimuli-responsive drug delivery systems where drug release is triggered by near-infrared light exposure.

Economic analysis indicates global demand for this compound could reach $18 million annually by 2030 driven primarily by expanding regenerative medicine applications. Current market leaders like Sigma-Aldrich and Alfa Aesar report consistent year-on-year growth exceeding industry averages due to increasing adoption in academic research labs investigating bioorthogonal chemistry and click reactions involving strained sulfur rings.

Safety profiles established through OECD toxicity tests confirm low acute toxicity with LD?? values exceeding 5 g/kg in rodent models—making it suitable for preclinical trials without requiring hazardous substance handling protocols under REACH regulations. This favorable safety profile aligns with current trends toward developing environmentally benign chemical building blocks emphasized in EU’s Chemical Strategy for Sustainability roadmap.

Ongoing collaborations between computational chemists at Stanford University and industrial partners are leveraging machine learning models trained on quantum mechanical datasets of organosulfur compounds like the 1,5-dithiacyclooctan-3-ol. These efforts aim to predict optimal substituent patterns for enhancing bioavailability when used as prodrugs—results presented at the 2024 ACS National Meeting suggest substituents at positions 7 or 8 could increase intestinal absorption rates by up to threefold without compromising metabolic stability.

• 31805-83-1(1,3-Bis(methylthio)-2-propanol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)